Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Published 25/03/2024, 13:00
© Reuters.  Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Harrow

  • The Trade: Harrow, Inc. (NASDAQ: HROW) 10% owner Opaleye Management Inc. acquired a total of 50,600 shares an average price of $9.65. To acquire these shares, it cost around $488,290.
  • What’s Happening: On March 19, Harrow reported worse-than-expected fourth-quarter financial results.
  • What Harrow Does: Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market.
Greenwich LifeSciences
  • The Trade: Greenwich LifeSciences, Inc. (NASDAQ: GLSI) CEO and CFO Snehal Patel acquired a total of 1,500 shares at an average price of $17.68. To acquire these shares, it cost around $26,520.
  • What’s Happening: On March 12, Greenwich LifeSciences announced the initiation of the first clinical sites in Europe in collaboration with GEICAM in Spain.
  • What Greenwich LifeSciences Does: Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

BRT Apartments

  • The Trade: BRT Apartments Corp. (NYSE: BRT) 10% owner Gould Investors L P bought a total of 3,471shares at an average price of $16.26. To acquire these shares, it cost around $56,450.
  • What’s Happening: On March 12, BRT Apartments posted downbeat quarterly sales.
  • What BRT Apartments Does: BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties.

Check This Out: Top 5 Consumer Stocks That May Crash This Month

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.